Cargando…
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
To compare patients with primary immune thrombocytopenia (ITP) prescribed early (within 3 months of initial ITP treatment) second-line treatment (eltrombopag, romiplostim, rituximab, immunosuppressive agents, splenectomy) with or without concomitant first-line therapy to those who received only firs...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345059/ https://www.ncbi.nlm.nih.gov/pubmed/37300567 http://dx.doi.org/10.1007/s00277-023-05289-0 |